VSL Pharmaceuticals   Report issue

For profit Phase 2 Phase 3
Founded: Gaithersburg MD United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2004
NCT00099723
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

ACTIAL Farmaceutica Lda | Actial Farmaceutica S.r.l. | CD Investments srl | VSL Pharmaceuticals

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ascites (Phase 2)

Crohn Disease (Phase 3)

Fatty Liver (Phase 1)

Fibrosis (Phase 2)

Liver Cirrhosis (Phase 2)

Peritonitis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 14